1. Introduction
Microbial life is a tapestry of complexity, woven from countless interactions, adaptations, and evolutionary strategies that span environmental niches and host organisms. Historically, microbiology focused on the identification and characterization of individual species. Today, advances in multi-omics technologies—encompassing genomics, transcriptomics, proteomics, and metabolomics—allow scientists to examine entire microbial ecosystems and their dynamic interplay with hosts at an unprecedented resolution (Ahmed, Roy, Khan, Septer, & Umar, 2016; Goodwin, McPherson, & McCombie, 2016). These integrative approaches are especially pertinent in understanding fungi like those in the genus Diaporthe, which exemplify remarkable phenotypic plasticity and ecological versatility. Diaporthe species are known to occupy diverse roles as plant pathogens, saprobes, and endophytes, adjusting their lifestyle based on environmental stress and host health (Gomes et al., 2013). Beyond their agricultural relevance, where they are notorious for causing diseases such as dieback, stem cankers, and seed decay, these fungi serve as a model for exploring the principles of microbial adaptation that also govern human gut ecosystems (Hilário & Gonçalves, 2023; Mena, Garaycochea, Stewart, Montesano, & Ponce De León, 2022).
Environmental microbial communities act as vast reservoirs for potential human pathogens, providing evolutionary "training grounds" in which organisms develop the molecular machinery necessary to adapt to complex hosts (Aujoulat et al., 2012; Greub & Raoult, 2004). Evolutionary pre-adaptation often occurs in environmental hotspots, such as the rhizosphere or in association with invertebrates and protozoa, allowing microbes to acquire metabolic versatility, resistance to stress, and mechanisms for immune evasion before colonizing humans (Alves, Zamith-Miranda, Frases, & Nosanchuk, 2025; Waterfield, Czirják, & Doré, 2004). For example, the capacity of Diaporthe species to metabolize diverse plant compounds parallels the strategies employed by gut fungi and bacteria to survive the chemically and immunologically challenging environment of the human gastrointestinal tract (Alves et al., 2025; Aujoulat et al., 2012). Similarly, opportunistic bacteria like Pseudomonas aeruginosa showcase a "Swiss Army knife" genome, where an array of genes supports adaptation to multiple hosts, including humans (Mathee et al., 2008; Stover et al., 2000). Understanding these cross-kingdom evolutionary principles is critical for dissecting the mechanisms underlying microbial plasticity and host-pathogen interactions.
In humans, the gut microbiome represents one of the most complex ecosystems, encompassing over a thousand bacterial species alongside fungi, viruses, and archaea (Ahmed et al., 2016; Savage, 1977). Dysbiosis—a disruption in the balance between commensal and pathogenic organisms—has been implicated in multifactorial disorders such as Inflammatory Bowel Disease (IBD), including Crohn’s disease and ulcerative colitis (Ahmed et al., 2016; Fiocchi, 2012). Multi-omics approaches have revolutionized our understanding of these diseases by revealing metabolic fingerprints, genomic signatures, and transcriptional shifts associated with microbial dysbiosis. For instance, metabolomics studies identify unique fungal metabolites that modulate host immunity, such as the ability of Candida albicans to alter tryptophan metabolism, thereby dampening pro-inflammatory responses and promoting survival (Alves et al., 2025; Cheng et al., 2010). These findings echo mechanisms observed in plant-fungal interactions, where Diaporthe secretes effector proteins to suppress host defenses during colonization (Mena et al., 2022; O’Connell et al., 2012). Thus, comparative studies across environmental, plant, and human hosts offer a holistic view of microbial adaptation strategies.
The genus Diaporthe exemplifies the duality of microbial life, capable of oscillating between beneficial endophytism and pathogenicity depending on contextual cues (Hilário & Gonçalves, 2023). This plasticity is underpinned by a rich complement of hydrolytic enzymes, biosynthetic gene clusters, and secondary metabolite pathways. Genomic analyses of Diaporthe species reveal genes encoding cellulases, pectinases, and ligninases, enabling the degradation of complex plant cell wall components and facilitating colonization (Hilário & Gonçalves, 2023; Mena et al., 2022). In parallel, biosynthetic gene clusters orchestrate the production of toxic metabolites such as fusicoccin A and ACT-toxin II, which play critical roles in pathogenesis (Li, Darwish, Alkharouf, Musungu, & Matthews, 2017; Mena et al., 2022). Transcriptomic approaches, particularly dual RNA-Seq, provide a simultaneous lens on host and pathogen gene expression, illuminating the intricate cross-talk between fungal effectors and plant defense proteins, including chitinases and ß-1,3-glucanases (Hilário & Gonçalves, 2023; Mena et al., 2022). This dual perspective parallels studies in human gut microbiomes, where integrative multi-omics captures interactions between host immune responses and microbial metabolites in health and disease (Ahmed et al., 2016; Alves et al., 2025).
The evolutionary trajectory of fungal pathogens that infect humans often originates in environmental niches. Fungi encountering predatory amoebae or invertebrate hosts in the environment acquire survival traits, such as resistance to oxidative stress, that are advantageous in mammalian hosts (Aujoulat et al., 2012; Schmitz-Esser et al., 2010). Similarly, bacteria such as Pseudomonas aeruginosa and Candidatus Amoebophilus asiaticus demonstrate conserved mechanisms for host interaction, highlighting the continuity of adaptive strategies across ecological boundaries (Mathee et al., 2008; Schmitz-Esser et al., 2010). These insights are instrumental for understanding opportunistic infections in immunocompromised individuals and for identifying potential therapeutic targets.
Secondary metabolites, produced by Diaporthe and other fungi, hold enormous pharmacological potential. Compounds such as polyketides, terpenes, melanin, and antibiotics are not only critical for survival under environmental stress but also form the backbone of human therapeutics, including penicillin, immunosuppressants, and anticancer agents (Alves et al., 2025; Bills & Gloer, 2016; Chepkirui & Stadler, 2017; Dighton, Tugay, & Zhdanova, 2008). Melanin, for instance, provides protection against extreme environmental conditions, including ionizing radiation, demonstrating the adaptive versatility of fungi and their biochemical relevance to human applications (Dadachova & Casadevall, 2008; Alves et al., 2025). By leveraging these naturally evolved compounds, researchers can design novel strategies to counteract pathogen resistance and mitigate disease progression.
Multi-omics integration—spanning genomics, transcriptomics, proteomics, and metabolomics—offers a systematic framework for capturing the full spectrum of microbial functionality (Ahmed et al., 2016; Hilário & Gonçalves, 2023). In the human gut, these approaches enable the identification of metabolic pathways, detection of early biomarkers, and discovery of novel therapeutic targets (Resurreccion & Fong, 2022; Jansson et al., 2009). Such integrative analysis has illuminated how microbial communities respond to dietary shifts, inflammation, and host immunity, providing actionable insights for precision medicine. Similarly, understanding lifestyle transitions in Diaporthe may inform strategies to prevent plant diseases and offer models for investigating opportunistic fungal infections in humans (Hilário & Gonçalves, 2023; Ahmed et al., 2016).
In conclusion, research on the genus Diaporthe exemplifies the convergence of environmental, plant, and human microbiology, revealing fundamental principles of microbial adaptation, cross-talk, and chemical versatility. By examining the molecular machinery that allows fungi to toggle between endophytism and pathogenicity, scientists can draw parallels to gut microbial dynamics, uncovering pathways that contribute to health and disease. This integrative perspective underscores the value of multi-omics as a "Swiss Army knife" for microbiology—allowing researchers to map not only microbial presence but also the biochemical and transcriptional conversations that shape host-microbe interactions (Ahmed et al., 2016; Alves et al., 2025). Ultimately, the combined study of Diaporthe and human gut microbiota through systematic and meta-analytic frameworks holds promise for advancing both plant pathology and human health, providing a blueprint for personalized interventions and novel therapeutics.